5-Amino-1-(2,3-dichloro-phenyl)-3-methyl-1H-pyrazole-4-carbonitrile, 95.0%, 1g

5-Bromo-2-methyl-1,3-dinitrobenzene, 95.0%, 500g

Ethylene glycol monobutyl ether, 99% min, for synthesis, 2.5 L, glass packaging

Glycine, N-2-pyrimidinyl-, methyl ester, 98%, 1g

Ethyl 3-methyl-5-cyclohexen-1-one-2-carboxylate, 95+%, 250mg

Pyridine hydrobromide perbromide, 90.0%, 100g

BETA-ASARONE, 95%, 5mg

1-(7-Methoxy-4-methylquinazolin-2-yl)guanidine, 98.0%, 5mg

4-Bromo-2-fluorobenzoyl chloride, 95.0%, 25g

5-Nitro-1H-indole-3-carbaldehyde, 95.0%, 25g

4-[(1,3-benzothiazol-2-yl)methyl]aniline, 97%, 250mg

MARBOFLOXACIN, 97%, 5g

Ethyl 2-bromo-5-fluoroisonicotinate, 95%, 5g